文献速递头颈外科

双时间点18F-氟脱氧葡萄糖正电子发射断层扫描/CT计算的代谢肿瘤负荷在口咽或下咽癌患者中的预后价值

Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer.
PubMed 文献 · Head Neck · 2018-12-10

本研究纳入42例接受放化疗前双时间点FDG-PET/CT的局部晚期口咽或下咽癌患者,测量早期和延迟相的SUVmax、MTV和TLG。结果显示早期相TLG2.5是PFS的独立预后因素(P = .005),而百分比变化并非显著预后因素。

要点

  • 双时间点FDG-PET/CT中早期相TLG2.5是局部晚期口咽或下咽癌PFS的独立预后因素(P = .005)。
  • ΔSUVmax、两相MTV2.5和TLG2.5、早期TLG40%、ΔTLG2.5和ΔTLG40%均与PFS显著相关。
  • 预后价值来自早期相计算的参数值而非百分比变化。

核心结论

  • 双时间点FDG-PET/CT中,早期相计算的若干参数值而非百分比变化与局部晚期口咽或下咽癌患者结局显著相关。

研究设计与样本

  • 本研究纳入42例(35男7女,38-73岁)局部晚期口咽或下咽癌患者,均在接受放化疗前进行FDG-PET/CT检查。
  • 测量早期和延迟相的SUVmax、MTV和TLG,统计分析包括受试者工作特征曲线、单因素和多因素分析。

主要发现

  • ΔSUVmax、两相MTV2.5和TLG2.5、早期TLG40%、ΔTLG2.5和ΔTLG40%均与无进展生存期(PFS)显著相关。
  • 多因素分析中,早期TLG2.5(P = .005)是PFS的独立预后因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study investigates the prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)/CT in patients with locally advanced cancer. METHODS: This study examines 42 patients (35 men and 7 women, 38-73 years old) with locally advanced oropharyngeal or hypopharyngeal cancer who had undergone FDG-PET/CT before receiving chemoradiotherapy. Maximum standardized uptake value (SUVmax ), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured for the early and delayed phases. Statistical analyses included receiver operating characteristic curve, univariate and multivariate analysis. RESULTS: ΔSUVmax , both phases of MTV2.5 and TLG2.5 , early TLG40% , ΔTLG2.5 , and ΔTLG40% were significantly associated with progression-free survival (PFS). In multivariate analysis, early TLG2.5 (P = .005) was an independent prognostic factor of PFS. CONCLUSION: Not the percent change but the value calculated in the early phase in several parameters using dual-time-point FDG-PET/CT is significantly associated with the outcomes of patients with locally advanced oropharyngeal or hypopharyngeal cancer.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Kuwabara H, Toriihara A, Yuasa-Nakagawa K, et al. Prognostic value of metabolic tumor burden calculated using dual-time-point 18F-fluorodeoxyglucose positron emission tomography/CT in patients with oropharyngeal or hypopharyngeal cancer. Head Neck. 2018. PMID: 30537436. doi:10.1002/hed.25490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。